BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36064312)

  • 1. The proportion and phenotypic changes of CD4
    Ju B; Zhu L; Wang J; Zheng J; Hao Z; Luo J; Zhang J; Hu N; An Q; Feng X; Huo Y; He L
    BMC Immunol; 2022 Sep; 23(1):41. PubMed ID: 36064312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (99) Tc-methylene diphosphonate improves rheumatoid arthritis disease activity by increasing the frequency of peripheral γδ T cells and CD4(+) CD25(+) Foxp3(+) Tregs.
    Su D; Shen M; Gu B; Wang X; Wang D; Li X; Sun L
    Int J Rheum Dis; 2016 Jun; 19(6):586-93. PubMed ID: 24467668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-1R1 is expressed on both Helios(+) and Helios(-) FoxP3(+) CD4(+) T cells in the rheumatic joint.
    Müller M; Herrath J; Malmström V
    Clin Exp Immunol; 2015 Oct; 182(1):90-100. PubMed ID: 26076982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tim3
    Sun H; Gao W; Pan W; Zhang Q; Wang G; Feng D; Geng X; Yan X; Li S
    Inflammation; 2017 Aug; 40(4):1342-1350. PubMed ID: 28478516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of soluble programmed death-1 protein in peripheral blood regulatory T cells and its effects on rheumatoid arthritis progression.
    Ren CF; Zhao YX; Hou CF; Luan L; Duan GQ; Li SJ; Zhao JH
    Mol Med Rep; 2017 Jan; 15(1):460-466. PubMed ID: 27909722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The change of CD4+ CD25+ regulatory T cells in patients with rheumatoid arthritis].
    Lin H; Zhang GD; Tang HH; Wang Y; Liu Y; Zhao Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Jul; 45(4):618-22. PubMed ID: 25286687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Increased percentage and defective inhibitory function of CD4
    Zhang R; Miao J; Zhang K; Zheng Z; Zhu P
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Nov; 35(11):961-966. PubMed ID: 31878990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective response of CD4(+) T cells to retinoic acid and TGFβ in systemic lupus erythematosus.
    Sobel ES; Brusko TM; Butfiloski EJ; Hou W; Li S; Cuda CM; Abid AN; Reeves WH; Morel L
    Arthritis Res Ther; 2011 Jun; 13(3):R106. PubMed ID: 21708033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased suppression of CD8
    Giri PS; Dwivedi M; Begum R
    Exp Dermatol; 2020 Aug; 29(8):759-775. PubMed ID: 32682346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The decreased proportion of CD4
    Yang D; Wu M
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Sep; 38(9):831-836. PubMed ID: 36082714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional improvement of regulatory T cells from rheumatoid arthritis subjects induced by capsular polysaccharide glucuronoxylomannogalactan.
    Pericolini E; Gabrielli E; Alunno A; Bartoloni Bocci E; Perito S; Chow SK; Cenci E; Casadevall A; Gerli R; Vecchiarelli A
    PLoS One; 2014; 9(10):e111163. PubMed ID: 25338013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased CD4
    Yin ZJ; Ju BM; Zhu L; Hu N; Luo J; He M; Feng XY; Lv XH; Pu D; He L
    Lupus; 2018 Nov; 27(13):2057-2068. PubMed ID: 30336752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
    Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
    J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated Circulating CD4
    Hu X; Gu Y; Zhao S; Hua S; Jiang Y
    Cancer Biother Radiopharm; 2019 Jun; 34(5):325-333. PubMed ID: 30925076
    [No Abstract]   [Full Text] [Related]  

  • 15. Low expressions of PD-L1 and CTLA-4 by induced CD4
    Zhao L; Zhou X; Zhou X; Wang H; Gu L; Ke Y; Zhang M; Ji X; Yang X
    Cytokine; 2020 Sep; 133():155119. PubMed ID: 32535334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification and phenotype of regulatory T cells in rheumatoid arthritis according to disease activity score-28.
    Sempere-Ortells JM; Pérez-García V; Marín-Alberca G; Peris-Pertusa A; Benito JM; Marco FM; Zubcoff JJ; Navarro-Blasco FJ
    Autoimmunity; 2009; 42(8):636-45. PubMed ID: 19886735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic and functional analysis of CD4+ CD25- Foxp3+ T cells in patients with systemic lupus erythematosus.
    Bonelli M; Savitskaya A; Steiner CW; Rath E; Smolen JS; Scheinecker C
    J Immunol; 2009 Feb; 182(3):1689-95. PubMed ID: 19155519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapamycin combined with allogenic immature dendritic cells selectively expands CD4+CD25+Foxp3+ regulatory T cells in rats.
    Wang GY; Zhang Q; Yang Y; Chen WJ; Liu W; Jiang N; Chen GH
    Hepatobiliary Pancreat Dis Int; 2012 Apr; 11(2):203-8. PubMed ID: 22484590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased proportion of CD4(+)CD25(+)Foxp3(+) regulatory T cells during early-stage sepsis in ICU patients.
    Leng FY; Liu JL; Liu ZJ; Yin JY; Qu HP
    J Microbiol Immunol Infect; 2013 Oct; 46(5):338-44. PubMed ID: 22921804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased apoptosis induction in CD4+ CD25+ Foxp3+ T cells contributes to enhanced disease activity in patients with rheumatoid arthritis through IL-10 regulation.
    Li N; Ma T; Han J; Zhou J; Wang J; Zhang J; Zheng S
    Eur Rev Med Pharmacol Sci; 2014; 18(1):78-85. PubMed ID: 24452947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.